Correlation Between Caribou Biosciences and Apogee Therapeutics,

Can any of the company-specific risk be diversified away by investing in both Caribou Biosciences and Apogee Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Caribou Biosciences and Apogee Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Caribou Biosciences and Apogee Therapeutics, Common, you can compare the effects of market volatilities on Caribou Biosciences and Apogee Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Caribou Biosciences with a short position of Apogee Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Caribou Biosciences and Apogee Therapeutics,.

Diversification Opportunities for Caribou Biosciences and Apogee Therapeutics,

0.24

Correlation Coefficient

Caribou Biosciences  Apogee Therapeutics,

Modest diversification

The 3 months correlation between Caribou and Apogee is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding Caribou Biosciences and Apogee Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apogee Therapeutics, and Caribou Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Caribou Biosciences are associated (or correlated) with Apogee Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apogee Therapeutics, has no effect on the direction of Caribou Biosciences i.e., Caribou Biosciences and Apogee Therapeutics, go up and down completely randomly.

Pair Corralation between Caribou Biosciences and Apogee Therapeutics,

Given the investment horizon of 90 days Caribou Biosciences is expected to under-perform the Apogee Therapeutics,. In addition to that, Caribou Biosciences is 1.19 times more volatile than Apogee Therapeutics, Common. It trades about -0.02 of its total potential returns per unit of risk. Apogee Therapeutics, Common is currently generating about 0.08 per unit of volatility. If you would invest  1,700  in Apogee Therapeutics, Common on September 23, 2024 and sell it today you would earn a total of  3,071  from holding Apogee Therapeutics, Common or generate 180.65% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	73.64%
Values	Daily Returns

Caribou Biosciences  vs.  Apogee Therapeutics, Common

Caribou Biosciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Caribou Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental drivers, Caribou Biosciences is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Apogee Therapeutics,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Apogee Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with Caribou Biosciences and Apogee Therapeutics,

The main advantage of trading using opposite Caribou Biosciences and Apogee Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Caribou Biosciences position performs unexpectedly, Apogee Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apogee Therapeutics, will offset losses from the drop in Apogee Therapeutics,'s long position.

The idea behind Caribou Biosciences and Apogee Therapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..